Clinical Trials Logo

Citation(s)

  •   Fauser S, Schwabecker V, Muether PS
    Suppression of intraocular vascular endothelial growth factor during aflibercept treatment of age-related macular degeneration. Am J Ophthalmol. 2014 Sep;158(3):532-6. doi: 10.1016/j.ajo.2014.05.025. Epub 2014 May 28.
  •   Garweg JG, Gerhardt C
    Disease stability and extended dosing under anti-VEGF treatment of exudative age-related macular degeneration (AMD) - a meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2021 Aug;259(8):2181-2192. doi: 10.1007/s00417-020-05048-1. Epub 2021 Feb 2.

Study Comparing Early Extension of Aflibercept and Brolucizumab in Wet AMD (SPARROW)

Details for clinical trial NCT04932980